Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content
Pc ctu logo 1

Our mission is to develop, deliver, interpret and disseminate patient-facing primary care research to the highest international standards.

The Primary Care Clinical Trials Unit is an integral part of the University of Oxford's Nuffield Department of Primary Care Health Sciences. Our research themes are aligned with the departmental priorities on infectious diseases, cardiovascular and metabolic disease, behavioural medicine and other topics of major national and international importance. In 2016 the unit recruited almost 6000 participants from around 600 sites in over 20 countries.

UKCRC Registered UnitThe unit is part of the Primary Care and Vaccine Collaborative Clinical Trials Unit (PCVC-CTU) consortium in recognition of its ability to coordinate high quality, academically-led, multi-centred clinical trials. We work closely with NHS Trusts across England and Wales and the UK Clinical Research Network.

Collaborate with us

Collaborate with us

We welcome requests to collaborate on research and support studies.

Collaborate with us
Software

Software

We develop our own bespoke clinical trial software, which is available for licensing.

Software
Trials portfolio

Trials portfolio

Our extensive study portfolio provides benefits to patient health and well-being.

Discover our research
Our expertise

Our expertise

Our multidisciplinary team deliver all aspects of primary care clinical research studies. 

Meet the team

Latest news

Finger prick blood test at gp surgery could safely reduce antibiotic use in patients with chronic obstructive pulmonary disease

Finger-prick blood test at GP surgery could safely reduce antibiotic use in patients with chronic obstructive pulmonary disease

Harmful placebos

Harmful placebos?

Oxford led droplet study informs nhs action to tackle obesity and type 2 diabetes

Oxford-led DROPLET study informs NHS action to tackle obesity and type 2 diabetes

Hundreds of thousands of people will receive help to battle obesity and Type 2 diabetes under radical new NHS plans to trial very low calorie diets for the first time.

More news

The unit is led by: